Graham Rowe is a visionary leader and the Co-founder & CEO of Guidepost Limited, a pioneering company dedicated to addressing the global diabetes crisis. Since its inception in 2012, Guidepost has emerged as South Africa’s foremost diabetes risk management solution for life and health insurers,...
Graham Rowe is a visionary leader and the Co-founder & CEO of Guidepost Limited, a pioneering company dedicated to addressing the global diabetes crisis. Since its inception in 2012, Guidepost has emerged as South Africa’s foremost diabetes risk management solution for life and health insurers, leveraging innovative technology to create impactful health outcomes. With over 450 million people living with diabetes worldwide, Graham is committed to transforming how diabetes care is delivered, emphasizing the importance of personalized nursing and human connection in managing this chronic condition.
Under Graham's leadership, Guidepost has developed a software-powered platform that enables scalable, personalized diabetes nursing. This approach not only enhances patient engagement but also significantly shifts the trajectory of the $820 billion global diabetes pandemic. By integrating strategic planning and management consulting expertise, Graham has successfully positioned Guidepost at the forefront of the healthcare technology sector, driving initiatives that improve patient outcomes while reducing healthcare costs.
Graham's extensive background in biotechnology and business strategy equips him with a unique perspective on the intersection of healthcare and technology. His skills in business analysis and strategy have been instrumental in navigating the complexities of the healthcare landscape, ensuring that Guidepost remains agile and responsive to the evolving needs of insurers and patients alike. As the company continues to expand its reach and impact, Graham remains focused on fostering human connections that are vital to effective diabetes management, reinforcing his belief that every interaction can make a difference in the lives of those affected by this chronic disease.
